UK Markets close in 2 hrs 45 mins

Oak Street Health, Inc. (OSH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
37.02-2.53 (-6.40%)
At close: 04:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 366.31
52-week low 329.84
50-day moving average 342.00
200-day moving average 353.19

Share statistics

Avg vol (3-month) 31.75M
Avg vol (10-day) 32.19M
Shares outstanding 5240.78M
Implied shares outstanding 6N/A
Float 8100.72M
% held by insiders 111.08%
% held by institutions 190.59%
Shares short (14 Sept 2021) 417.92M
Short ratio (14 Sept 2021) 411.77
Short % of float (14 Sept 2021) 417.21%
Short % of shares outstanding (14 Sept 2021) 47.44%
Shares short (prior month 12 Aug 2021) 415.56M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -27.55%
Operating margin (ttm)-27.43%

Management effectiveness

Return on assets (ttm)-16.95%
Return on equity (ttm)-172.39%

Income statement

Revenue (ttm)1.12B
Revenue per share (ttm)3.39
Quarterly revenue growth (yoy)64.70%
Gross profit (ttm)78.47M
EBITDA -293.02M
Net income avi to common (ttm)-218.32M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.08B
Total cash per share (mrq)4.48
Total debt (mrq)1.05B
Total debt/equity (mrq)473.55
Current ratio (mrq)3.40
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-116.02M
Levered free cash flow (ttm)-52.2M